http://orcid.org/0000-0003-3197-3414
References
- Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nature Rev Drug Discov. 2008;7:168–181.
- Supuran CT. Carbonic anhydrase inhibition and the management of hypoxic tumors. Metabolites. 2017;7:E48.
- Supuran CT, Alterio V, Di Fiore A, et al. Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one. Med Res Rev. 2018; in press. DOI:10.1002/med.21497.
- Supuran CT, Winum JY. Carbonic anhydrase IX inhibitors in cancer therapy: an update. Future Med Chem. 2015;7:1407–1414.
- Capasso C, Supuran CT. Inhibition of bacterial carbonic anhydrases as a novel approach to escape drug resistance. Curr Top Med Chem. 2017;17:1237–1248.
- Vermelho AB, Capaci GR, Rodrigues IA, et al. Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets. Bioorg Med Chem. 2017;25:1543–1555.
- Supuran CT. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov. 2017;12:61–88.
- Sismanopoulos N, Delivanis DA, Alysandratos KD, et al. Mast cells in allergic and inflammatory diseases. Curr Pharm Des. 2012;18:2261–2277.
- Theoharides TC, Alysandratos KD, Angelidou A, et al. Mast cells and inflammation. Biochim Biophys Acta. 2012;1822:21–33.
- Lu F, Huang S. The roles of mast cells in parasitic protozoan infections. Front Immunol. 2017;8:363.
- Modena BD, Dazy K, White AA. Emerging concepts: mast cell involvement in allergic diseases. Transl Res. 2016;174:98–121.
- Kubo M. Innate and adaptive type 2 immunity in lung allergic inflammation. Immunol Rev. 2017;278:162–172.
- Korhonen LK, Korhonen E. Histochemical demonstration of carbonic anhydrase activity in mast cells. Experientia. 1965;21:628–629.
- Kamsteeg M, Zeeuwen PL, De Jongh GJ, et al. Increased expression of carbonic anhydrase II (CA II) in lesional skin of atopic dermatitis: regulation by Th2 cytokines. J Invest Dermatol. 2007;127:1786–1789.
- Wen T, Mingler NK, Wahl B. Carbonic anhydrase IV is expressed on IL-5–activated murine eosinophils. J Immunol. 2014;192:5481–5489.
- Talibov VO, Linkuvienė V, Matulis D, et al. Kinetically selective inhibitors of human carbonic anhydrase isozymes I, II, VII, IX, XII, and XIII. J Med Chem. 2016;59:2083–2093.
- Henry EK, Sy CB, Inclan-Rico JM, et al. Carbonic anhydrase enzymes regulate mast cell-mediated inflammation. J Exp Med. 2016;213:1663–1673.
- Berrino E, Bua S, Mori M, et al. Novel Sulfonamide-containing compounds as selective carbonic anhydrase I inhibitors. Molecules. 2017;22:E1049.